- Home
- YELP vs GLPG Comparison
YELP vs GLPG Comparison
Compare YELP & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YELP
- GLPG
- Stock Information
- Founded
- YELP 2004
- GLPG 1999
- Country
- YELP United States
- GLPG Belgium
- Employees
- YELP N/A
- GLPG N/A
- Industry
- YELP Other Consumer Services
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- YELP Consumer Discretionary
- GLPG Health Care
- Exchange
- YELP Nasdaq
- GLPG Nasdaq
- Market Cap
- YELP 2.0B
- GLPG 2.1B
- IPO Year
- YELP 2012
- GLPG 2005
- Fundamental
- Price
- YELP $33.13
- GLPG $32.02
- Analyst Decision
- YELP Hold
- GLPG Hold
- Analyst Count
- YELP 6
- GLPG 4
- Target Price
- YELP $35.83
- GLPG $30.00
- AVG Volume (30 Days)
- YELP 789.5K
- GLPG 279.5K
- Earning Date
- YELP 11-06-2025
- GLPG 11-05-2025
- Dividend Yield
- YELP N/A
- GLPG N/A
- EPS Growth
- YELP 16.67
- GLPG N/A
- EPS
- YELP 2.19
- GLPG N/A
- Revenue
- YELP $1,451,224,000.00
- GLPG $323,674,692.00
- Revenue This Year
- YELP $6.16
- GLPG $1.77
- Revenue Next Year
- YELP $3.87
- GLPG $0.44
- P/E Ratio
- YELP $15.14
- GLPG N/A
- Revenue Growth
- YELP 5.37
- GLPG 5.43
- 52 Week Low
- YELP $29.96
- GLPG $22.36
- 52 Week High
- YELP $41.72
- GLPG $37.78
- Technical
- Relative Strength Index (RSI)
- YELP 56.73
- GLPG 41.53
- Support Level
- YELP $32.30
- GLPG $31.06
- Resistance Level
- YELP $33.54
- GLPG $35.00
- Average True Range (ATR)
- YELP 0.95
- GLPG 0.88
- MACD
- YELP 0.15
- GLPG -0.40
- Stochastic Oscillator
- YELP 81.57
- GLPG 16.16
About YELP Yelp Inc.
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.